Top Clinical Trials companies in South Korea by Operating Cash Flow
South Korea
# |
Name |
Operating Cash Flow |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
|---|---|---|---|---|---|---|---|
| 1 |
USD 412.54 M
|
Dec. 31, 2023 | USD 119.86 | -2.20% |
|
South Korea |
|
| 2 |
USD 26.34 M
|
Dec. 31, 2023 | USD 11.00 | -3.03% |
|
South Korea |
|
| 3 |
USD 6.40 M
|
Dec. 31, 2023 | USD 11.62 | -0.90% |
|
South Korea |
|
| 4 |
USD 997.16 K
|
Dec. 31, 2023 | USD 54.68 | -7.62% |
|
South Korea |
|
| 5 |
USD -1.53 M
|
Dec. 31, 2023 | USD 11.83 | -21.52% |
|
South Korea |
|
| 6 |
USD -5.96 M
|
Dec. 31, 2023 | USD 240.05 | -5.25% |
|
South Korea |
|
| 7 |
USD -7.88 M
|
Dec. 31, 2023 | USD 1.01 | -3.22% |
|
South Korea |
|
| 8 |
USD -8.35 M
|
Dec. 31, 2023 | USD 1.23 | -3.88% |
|
South Korea |
|
| 9 |
USD -8.43 M
|
Dec. 31, 2023 | USD 64.97 | -2.50% |
|
South Korea |
|
| 10 |
USD -16.26 M
|
Dec. 31, 2023 | USD 10.77 | -3.15% |
|
South Korea |
|
| 11 |
USD -16.70 M
|
Dec. 31, 2023 | USD 1.42 | -2.25% |
|
South Korea |
|
| 12 |
USD -16.93 M
|
Dec. 31, 2023 | USD 17.88 | -1.83% |
|
South Korea |
|
| 13 |
USD -20.20 M
|
Dec. 31, 2023 | USD 2.33 | -4.21% |
|
South Korea |
|
| 14 |
USD -21.78 M
|
Dec. 31, 2023 | USD 25.27 | 1.91% |
|
South Korea |
|
| 15 |
USD -24.89 M
|
Dec. 31, 2023 | USD 1.61 | -1.19% |
|
South Korea |
|
| 16 |
USD -29.23 M
|
Dec. 31, 2023 | USD 3.04 | -3.81% |
|
South Korea |
|
| 17 |
USD -72.35 M
|
Dec. 31, 2023 | USD 70.28 | -5.55% |
|
South Korea |
Frequently Asked Questions
-
Which Clinical Trials company in South Korea has the highest Operating Cash Flow ?
The Clinical Trials company in South Korea with the highest Operating Cash Flow is Celltrion, Inc. (KSE: 068270.KS) at USD 412.54 M.
-
Which Clinical Trials company in South Korea has the lowest Operating Cash Flow ?
The Clinical Trials company in South Korea with the lowest Operating Cash Flow is SK Biopharmaceuticals Co., Ltd. (KSE: 326030.KS) at USD -72.35 M.
-
What are the top 10 Clinical Trials companies in South Korea by Operating Cash Flow ?
The top 10 Clinical Trials companies in South Korea by Operating Cash Flow are Celltrion, Inc., Boditech Med Inc., Samjin Pharmaceuticals Co., Ltd., ST Pharm Co.,Ltd., Anterogen.Co.,Ltd., ALTEOGEN Inc., Enzychem Lifesciences Corporation, Gencurix Inc., Peptron, Inc. and OliX Pharmaceuticals,Inc.
-
What are the bottom 10 Clinical Trials companies in South Korea by Operating Cash Flow ?
The bottom 10 Clinical Trials companies in South Korea by Operating Cash Flow are SK Biopharmaceuticals Co., Ltd., Genexine, Inc., CrystalGenomics, Inc., ABL Bio Inc., MedPacto, Inc., Oscotec Inc., GeneOne Life Science, Inc., OliX Pharmaceuticals,Inc, Peptron, Inc. and Gencurix Inc..
